Search
for
Sort by
Research 30 of 90
- Symptomatology of Long COVID Associated with Inherited and Acquired Thrombophilic Conditions: A Systematic Review
- The Safety of Testosterone Therapy in Women
- Dermatological Manifestations of COVID-19: A Brief Review
- Women’s Health Considerations for Lipid Management
- The Association of Cutaneous Lichen Planus and Metabolic Syndrome: A Case-Control Study
- Embolic Stroke as the Initial Manifestation of Systemic Lupus Erythematosus
- Culprits of Medication-Induced Telogen Effluvium, Part 2
- Research gaps in medical treatment of transgender/nonbinary people
- COVID-19 and hypopituitarism
- Female doping: observations from a data lake study in the Hospital District of Helsinki and Uusimaa, Finland
- Signal Mining for Non-Bleeding Adverse Event in Novel Oral Anticoagulants: A Pharmacovigilance Study Based on the FAERS Database
- Sexual dysfunction, including hypoactive sexual desire disorder: Diagnosis and treatment recommendations
- Evaluation and Treatment of Gender Dysphoria to Prepare for Gender Confirmation Surgery
- Glucocorticoids and Risk of Venous Thromboembolism in Asthma Patients Aged 20–59 Years in the United Kingdom’s CPRD 1995–2015
- Oral contraceptive pill (OCP) treatment alters the gene expression of intercellular adhesion molecule-1 (ICAM-1), tumor necrosis factor-α (TNF-α), monocyte chemoattractant protein-1 (MCP-1) and plasminogen activator inhibitor-1 (PAI-1) in polycystic ovary syndrome (PCOS) women compared to drug-naive PCOS women
- Thrombophilia and Polycythemia in a Woman With Budd-Chiari Syndrome
- Skin manifestations associated with COVID-19
- Safety of testosterone use in women
- Role of plasminogen activator inhibitor type 1 (PAI-1) in PCOS patient
- The Clinical Presentation of Systemic Lupus Erythematosus
- STEROIDS AND STEROID-LIKE COMPOUNDS
- Ischemic Stroke in a Young Adult Male During Finasteride Therapy
- Targeting host cell proteases as a potential treatment strategy to limit the spread of SARS‐CoV‐2 in the respiratory tract
- Standards of Care for the Health of Transsexual, Transgender, and Gender-Nonconforming People, Version 7
- COVID-19 and Sex Differences
- Menopause and aging, quality of life and sexuality
- Hypersensitivity Reactions to Anticoagulant Drugs
- Cross-sex hormone therapy for gender dysphoria
- Male, Female, Other: Transgender and the Impact in Primary Care
- Symptom management in inflammatory bowel disease